Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on August 5, 2026

Aug. 5, 2026

CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 5, 2026

Medline Reports Second Quarter and First Six Months 2026 Results

Indeterminate GlobeNewswire

Aug. 5, 2026

BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer

Indeterminate GlobeNewswire

Aug. 5, 2026

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 5, 2026

Palvella Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 5, 2026

Bioventus Reports Second Quarter Financial Results

Indeterminate GlobeNewswire

Aug. 5, 2026

Kane Biotech Announces Engagement of DNA Advisors

Indeterminate GlobeNewswire

Aug. 5, 2026

Applied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial

Indeterminate GlobeNewswire

Aug. 5, 2026

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 5, 2026

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Indeterminate GlobeNewswire

Aug. 5, 2026

AC Immune First Half 2026 Financial and Corporate Update

Indeterminate GlobeNewswire

Aug. 5, 2026

Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire

Aug. 5, 2026

Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026

Indeterminate GlobeNewswire

Aug. 5, 2026

Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026

Indeterminate GlobeNewswire

Aug. 5, 2026

NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results

Indeterminate GlobeNewswire

Aug. 5, 2026

BioCryst Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 5, 2026

EyePoint Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate Developments

Indeterminate GlobeNewswire

Aug. 5, 2026

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Aug. 5, 2026

Entrada Therapeutics Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 5, 2026

Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs

Indeterminate GlobeNewswire